卵巢影像报告和数据系统（O-RADS）磁共振成像：我们现在所处的位置以及未来的发展方向？ - Suppr

Suppr

超能文献

O-RADS MRI: where are we and where we are going?

作者信息

Thomassin-Naggara Isabelle, Razakamanantsoa Leo, Rockall Andrea

机构信息

Service d'Imageries Radiologiques et Interventionnelles Spécialisées, APHP - Hôpital Tenon, Paris, France.

Inserm NSERM U938, Sorbonne Université, Paris, France.

出版信息

Eur Radiol. 2023 Nov;33(11):8155-8156. doi: 10.1007/s00330-023-09732-8. Epub 2023 May 13.

DOI:10.1007/s00330-023-09732-8

PMID:37178201

Abstract

摘要

相似文献

O-RADS MRI: where are we and where we are going?卵巢影像报告和数据系统（O-RADS）磁共振成像：我们现在所处的位置以及未来的发展方向？

Eur Radiol. 2023 Nov;33(11):8155-8156. doi: 10.1007/s00330-023-09732-8. Epub 2023 May 13.

Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.使用磁共振成像对肝细胞癌进行无创诊断时LI-RADS 2018与KLCA-NCC 2018的比较

Clin Mol Hepatol. 2020 Jul;26(3):340-351. doi: 10.3350/cmh.2020.0004. Epub 2020 Jun 4.

Comparison of Contrast-Enhanced Ultrasound versus Contrast-Enhanced Magnetic Resonance Imaging for the Diagnosis of Focal Liver Lesions Using the Liver Imaging Reporting and Data System.对比增强超声与对比增强磁共振成像在肝脏影像报告与数据系统诊断局灶性肝脏病变中的比较。

Ultrasound Med Biol. 2020 May;46(5):1216-1223. doi: 10.1016/j.ultrasmedbio.2020.01.023. Epub 2020 Feb 27.

Added Value of Quantitative Analysis of Diffusion-Weighted Imaging in Ovarian-Adnexal Reporting and Data System Magnetic Resonance Imaging.扩散加权成像定量分析在卵巢-附件报告和数据系统磁共振成像中的附加价值。

J Magn Reson Imaging. 2022 Jul;56(1):158-170. doi: 10.1002/jmri.28003. Epub 2021 Nov 19.

Accuracy and reproducibility of the O-RADS MRI risk stratification system based on enhanced non-DCE MRI in the assessment of adnexal masses.基于增强非动态对比增强磁共振成像（MRI）的O-RADS MRI风险分层系统在附件包块评估中的准确性和可重复性

Eur J Radiol. 2023 Feb;159:110670. doi: 10.1016/j.ejrad.2022.110670. Epub 2022 Dec 24.

Diagnostic efficacy of contrast-enhanced ultrasound versus MRI Liver Imaging Reporting and Data System (LI-RADS) for categorising hepatic observations in patients at risk of hepatocellular carcinoma.超声造影与 MRI 肝脏影像报告与数据系统（LI-RADS）对肝癌高危患者肝脏观察病灶分类的诊断效能。

Clin Radiol. 2021 Feb;76(2):161.e1-161.e10. doi: 10.1016/j.crad.2020.10.009. Epub 2020 Nov 14.

Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.结合增强磁共振和弥散加权成像阅读适应“乳腺影像报告和数据系统”的多参数 3-T 成像乳腺病变。

Eur Radiol. 2013 Jul;23(7):1791-802. doi: 10.1007/s00330-013-2771-8. Epub 2013 Mar 16.

LI-RADS Major Features on MRI for Diagnosing Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.LI-RADS 磁共振成像诊断肝细胞癌的主要特征：系统评价和荟萃分析。

J Magn Reson Imaging. 2021 Aug;54(2):518-525. doi: 10.1002/jmri.27570. Epub 2021 Feb 27.

Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.联合 b2500 弥散加权成像与 BI-RADS 提高了乳腺 MRI 的特异性。

Diagn Interv Imaging. 2023 Sep;104(9):410-418. doi: 10.1016/j.diii.2023.05.001. Epub 2023 May 18.

Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.高危人群肝细胞癌无创诊断标准化算法的观察者间和模态间一致性：CEUS-LI-RADS 与 MRI-LI-RADS。

Eur Radiol. 2018 Oct;28(10):4254-4264. doi: 10.1007/s00330-018-5379-1. Epub 2018 Apr 19.

引用本文的文献

Differentiating struma ovarii from FIGO stage I malignant ovarian tumors in O-RADS MRI 5 lesions: a targeted cohort study.在O-RADS MRI 5类病变中鉴别卵巢甲状腺肿与FIGO I期恶性卵巢肿瘤：一项针对性队列研究。

Abdom Radiol (NY). 2025 Mar;50(3):1426-1434. doi: 10.1007/s00261-024-04564-6. Epub 2024 Sep 14.

本文引用的文献

Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Counterpoint-Hepatobiliary Contrast Agents Improve Detection and Characterization.

AJR Am J Roentgenol. 2024 Apr;222(4):e2330140. doi: 10.2214/AJR.23.30140. Epub 2023 Oct 4.

O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates.O-RADS MRI：诊断性能和分类恶性率的系统评价和荟萃分析。

Radiology. 2023 Apr;307(1):e220795. doi: 10.1148/radiol.220795. Epub 2022 Nov 22.

How to improve O-RADS MRI score for rating adnexal masses with cystic component?如何提高 O-RADS MRI 评分以评估具有囊性成分的附件肿块？

Eur Radiol. 2022 Sep;32(9):5943-5953. doi: 10.1007/s00330-022-08644-3. Epub 2022 Mar 24.

Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working Group.卵巢癌计算机断层扫描（CT）和磁共振（MR）成像报告词汇表，由 SAR 子宫和卵巢癌疾病重点小组和 ESUR 女性盆腔成像工作组制定。

Eur Radiol. 2022 May;32(5):3220-3235. doi: 10.1007/s00330-021-08390-y. Epub 2021 Nov 30.

Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.卵巢-附件报告数据系统磁共振成像（O-RADS MRI）评分用于超声不确定附件肿块的风险分层。

JAMA Netw Open. 2020 Jan 3;3(1):e1919896. doi: 10.1001/jamanetworkopen.2019.19896.

ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update.超声检查无法确定的附件包块的磁共振成像的欧洲泌尿生殖放射学会（ESUR）建议：更新版

Eur Radiol. 2017 Jun;27(6):2248-2257. doi: 10.1007/s00330-016-4600-3. Epub 2016 Oct 21.

Adnexal masses: development and preliminary validation of an MR imaging scoring system.附件肿块：磁共振成像评分系统的发展与初步验证。

Radiology. 2013 May;267(2):432-43. doi: 10.1148/radiol.13121161. Epub 2013 Mar 6.

Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.动态增强磁共振成像在鉴别卵巢纤维瘤和浆膜下子宫肌瘤中的价值。

J Comput Assist Tomogr. 2007 Mar-Apr;31(2):236-42. doi: 10.1097/01.rct.0000237810.88251.9e.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验